BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9845546)

  • 21. Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study.
    Borowitz MJ; Rubnitz J; Nash M; Pullen DJ; Camitta B
    Leukemia; 1998 Nov; 12(11):1764-70. PubMed ID: 9823952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
    Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
    J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of TEL/AML1 fusion in pediatric AML: further evidence for lineage specificity of TEL/AML1.
    Loh ML; McLean TW; Buckley JD; Howells W; Gilliland DG; Smith FO
    Leuk Res; 1998 May; 22(5):461-4. PubMed ID: 9652733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
    Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of the TEL-AML1 fusion gene in pediatric acute lymphoblastic leukemia in Turkey.
    Ozbek U; Sirma S; Agaoglu L; Yuksel L; Anak S; Yildiz I; Devecioglu O; Timur C; Meral A; Gedikoglu G
    J Pediatr Hematol Oncol; 2003 Mar; 25(3):204-8. PubMed ID: 12621238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia.
    Uckun FM; Pallisgaard N; Hokland P; Navara C; Narla R; Gaynon PS; Sather H; Heerema N
    Leuk Lymphoma; 2001 Jun; 42(1-2):41-56. PubMed ID: 11699220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia.
    de Haas V; Oosten L; Dee R; Verhagen OJ; Kroes W; van den Berg H; van der Schoot CE
    Br J Haematol; 2000 Dec; 111(4):1080-6. PubMed ID: 11167743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular detection of TEL-AML1 transcripts as a diagnostic tool and for monitoring of minimal residual disease in B-lineage childhood acute lymphoblastic leukemia.
    Park HJ; Lee KE; Um JM; Choe SY; Chi XZ; Lee JA; Shin HY; Ahn HS; Bae SC
    Mol Cells; 2000 Feb; 10(1):90-5. PubMed ID: 10774753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Frequency of TEL/AML1 and BCR/ABL fusion genes in children with acute lymphoblastic leukemia].
    Artigas A CG; Cabrera C ME; Melo A A; Páez F E; Arriagada M M; Astete A C; Roa E I; Roa S JC
    Rev Med Chil; 2006 Nov; 134(11):1367-76. PubMed ID: 17277849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan.
    Liang DC; Chou TB; Chen JS; Shurtleff SA; Rubnitz JE; Downing JR; Pui CH; Shih LY
    Leukemia; 1996 Jun; 10(6):991-3. PubMed ID: 8667657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia.
    Gandemer V; Rio AG; de Tayrac M; Sibut V; Mottier S; Ly Sunnaram B; Henry C; Monnier A; Berthou C; Le Gall E; Le Treut A; Schmitt C; Le Gall JY; Mosser J; Galibert MD
    BMC Genomics; 2007 Oct; 8():385. PubMed ID: 17956600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
    Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
    Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AML1 gene over-expression in childhood acute lymphoblastic leukemia.
    Mikhail FM; Serry KA; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Coignet L; Nucifora G
    Leukemia; 2002 Apr; 16(4):658-68. PubMed ID: 11960347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of the Der (21)t(12;21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia.
    Kobayashi H; Satake N; Kaneko Y
    Leuk Lymphoma; 1997 Dec; 28(1-2):43-50. PubMed ID: 9498702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification.
    Maloney K; McGavran L; Murphy J; Odom L; Stork L; Wei Q; Hunger S
    Leukemia; 1999 Nov; 13(11):1708-12. PubMed ID: 10557042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines.
    Kim DH; Moldwin RL; Vignon C; Bohlander SK; Suto Y; Giordano L; Gupta R; Fears S; Nucifora G; Rowley JD
    Blood; 1996 Aug; 88(3):785-94. PubMed ID: 8704231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.